| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
Methanone, (2,6-dimethoxyphenyl)[4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]- manufacturers
- MUN57694
-
- $51.00
-
2026-07-15
- CAS:858557-69-4
- Purity: 99.24%
- Supply Ability: 10g
|
| | Methanone, (2,6-dimethoxyphenyl)[4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]- Basic information |
| Product Name: | Methanone, (2,6-dimethoxyphenyl)[4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]- | | Synonyms: | Methanone, (2,6-dimethoxyphenyl)[4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]-;MUN57694;26S proteasome inhibitor I;Proteasome,Inhibitor,inhibit,MUN57694,MUN-57694;(2,6-Dimethoxyphenyl)[4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]methanone;MUN57694, 10 mM in DMSO;20S Proteasome-IN-1;(2,6-Dimethoxyphenyl)(4-(3-(p-tolyl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)methanone | | CAS: | 858557-69-4 | | MF: | C23H25N3O4 | | MW: | 407.46 | | EINECS: | | | Product Categories: | | | Mol File: | 858557-69-4.mol | ![Methanone, (2,6-dimethoxyphenyl)[4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]- Structure](CAS/20210111/GIF/858557-69-4.gif) |
| | Methanone, (2,6-dimethoxyphenyl)[4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]- Chemical Properties |
| Boiling point | 621.2±65.0 °C(Predicted) | | density | 1+-.0.06 g/cm3(Predicted) | | storage temp. | 4°C, protect from light | | solubility | DMSO : 31.25 mg/mL (76.69 mM; ultrasonic and warming and heat to 60°C) | | form | Solid | | pka | -0.58±0.44(Predicted) | | color | White to off-white |
| | Methanone, (2,6-dimethoxyphenyl)[4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]- Usage And Synthesis |
| Uses | 20S Proteasome-IN-1 is a 26S proteasome inhibitor extracted from patent WO2006128196A2 compound 2. 20S Proteasome-IN-1 has the potential for cancer, immune-related disorders, inflammation, ischemic conditions, neurodegenerative disorders and other diseases research[1]. | | Biological Activity | 20S Proteasome-IN-1 is a 26S proteasome inhibitor extracted from patent WO2006128196A2 compound 2. 20S Proteasome-IN-1 has the potential for cancer, immune-related disorders, inflammation, ischemic conditions, neurodegenerative disorders and other diseases research[1]. | | References | [1]. Parlati F, et, al. Novel substrate for rpn 11 enzymatic activity. WO2006128196A2. |
| | Methanone, (2,6-dimethoxyphenyl)[4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]- Preparation Products And Raw materials |
|